MarketInOut Stock Screener Log In | Sign Up

Medexus Pharmaceuticals Inc

TSX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 16:00
Medexus Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSX
Market Capitalization154.93 mln
Float28.74 mln
Earnings Date11/11/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.87
Likely reliable

Relative Strength

82 / 100
Strongly outperforming

Debt / Equity

0.55
Moderate leverage

Pre-Tax Margin

-2%
Barely loss-making

ROE

-4.58
Negative

Business Description

Medexus Pharmaceuticals is a Canadian-based company that develops and sells prescription and over-the-counter medicines across both Canada and the United States. Founded in 2000 and headquartered in Toronto, the company addresses a broad range of medical conditions, including blood disorders, autoimmune diseases, cancer, allergies, and rare diseases. Its portfolio spans treatments such as injectable therapies, oral solutions, topical products, and surgical imaging agents, serving both adult and pediatric patients.

Key Fundamentals

EPS-0.10
ROE-4.58
RPS4.55
ROIC5.87
ROA-1.56
Interest Cover2.65
EBITDA, mln13.52
EV / EBITDA14.23
EV / EBIT2,317
Revenue, mln143
EV / Revenue1.35

Quote Details

Last 4.97
Change 0.1 (2.05%)
Open 4.87
Volume 31,502
Turnover 156,565
Average Volume 35,481

Financial Ratios

Pre-Tax Profit Margin-2
Leverage Ratio2.96
Current Ratio1.30
Price / Book2.31
Price / Cash Flow8.10
Price / Free Cash Flow9.42
Debt / Equity0.55
Price / Sales1.13

Financial Strength

Altman Z-Score0.92
Piotroski F-Score 5 / 9
Beneish M-Score-2.87
Price to Intrinsic Value1.20
Short Ratio3.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.02% 74 / 100   
1 Month -2.93% 33 / 100   
2 Months -2.17% 30 / 100   
6 Months 22.72% 90 / 100   
1 Year 73.17% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog